The global Nasal Spray Vaccine market was valued at US$ 140.8 million in 2022 and is projected to reach US$ 179.6 million by 2029, at a CAGR of 3.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Nasal Spray Vaccine refers to a vaccine injected through the nose, which is mostly used for influenza.
The FluMist is the only alternative to the flu shot without a needle and is given in the form of a nasal spray.
Nasal Spray Vaccine Market aims to provide a comprehensive presentation of the global market for Nasal Spray Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nasal Spray Vaccine. Nasal Spray Vaccine Market contains market size and forecasts of Nasal Spray Vaccine in global, including the following market information:
- Global Nasal Spray Vaccine Market Revenue, 2018-2023, 2024-2032, ($ millions)
- Global top five companies in 2022 (%)
Nasal Spray Vaccine is widely sales for Child and Adult The most proportion of Nasal Spray Vaccine is for Adult, and the consumption proportion is about 68% in 2019.
Europe is the largest consumption place, with a consumption market share nearly 80% in 2019. Following Europe, North America is the second largest consumption place.
Market competition is intense. AstraZeneca, Cipla, BCHT the leaders of the industry, and hold key technologies, with high-end customers, they are also the main international exporters. However, with further expanding market, there will be more manufactures in the future.
Europe is the largest consumption place, with a consumption market share nearly 80% in 2019. Following Europe, North America is the second largest consumption place.
Market competition is intense. AstraZeneca, Cipla, BCHT the leaders of the industry, and hold key technologies, with high-end customers, they are also the main international exporters. However, with further expanding market, there will be more manufactures in the future.
We surveyed the Nasal Spray Vaccine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nasal Spray Vaccine Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Nasal Spray Vaccine Market Segment Percentages, by Type, 2022 (%)
- Flu Vaccine
- COVID-19 Vaccine
- Other Vaccines
Global Nasal Spray Vaccine Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Nasal Spray Vaccine Market Segment Percentages, by Application, 2022 (%)
Global Nasal Spray Vaccine Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Nasal Spray Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Nasal Spray Vaccine revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Nasal Spray Vaccine revenues share in global market, 2022 (%)
key players include:
- AstraZeneca Group
- BioDiem
- Endo International
- Antares Pharma
- PharmaJet
- Bioject Medical Technologies Inc
- INJEX Pharma AG
- Crossject SA
Outline of Major Chapters:
Chapter 1: Introduces the definition of Nasal Spray Vaccine, market overview.
Chapter 2: Global Nasal Spray Vaccine market size in revenue.
Chapter 3: Detailed analysis of Nasal Spray Vaccine company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Nasal Spray Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
Industry Market Size
